4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001708599-25-000071
Chief Scientific Officer sold 6,500 shares at $5.01 ($32,565)
- Chief Scientific Officer acquired 6,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moreadith Randall Chief Scientific Officer | 2025-07-14 | Option exercise | +6,500 | $0.06 | $390 | 6,500 | D |
| Moreadith Randall Chief Scientific Officer | 2025-07-14 | Sale | −6,500 | $5.01 | $32,565 | 0 | D |
| Derivatives | |||||||
| Moreadith Randall Chief Scientific Officer | 2025-07-14 | Option exercise · Stock Option (right to buy) | −6,500 | 501,686 | D | ||
| Open-market sales · 6,500 sh · avg $5.01 · $32,565 | |||||||
Loading xslF345X05/wk-form4_1752763244.xml…